On the other hand, in cSCC non-RDEB, HMGB1 overexpression in immunohistochemistry seems to be correlated to tumor progression, owing to the close link between this mediator and the tumor’s invasive and metastatic potential [9,10]. Here, HMGB1 is linked to neoplasm.